Esperion Therapeutics Inc (NASDAQ: ESPR)
Esperion Therapeutics Inc (ESPR) with a beta value of 1.04 appears to be a promising investment opportunity.
Sana Meer
Esperion Therapeutics Inc (NASDAQ: ESPR) on Tuesday, plunged -3.39% from the previous trading day, before settling in for the closing ...
A major move is in the offing as Esperion Therapeutics Inc (ESPR) market cap hits 671.71 million
Steve Mayer
On Monday, Esperion Therapeutics Inc (NASDAQ: ESPR) opened higher 7.01% from the last session, before settling in for the closing ...
Esperion Therapeutics Inc (ESPR)’s latest performance is not what we had anticipated
Zack King
A new trading day began on Friday, with Esperion Therapeutics Inc (NASDAQ: ESPR) stock price up 13.79% from the previous ...
